BERWYN,
Pa., May 2, 2024 /PRNewswire/ -- AMETEK, Inc.
(NYSE: AME) today announced its financial results for the first
quarter ended March 31, 2024.
AMETEK's first quarter 2024 sales were a record $1.74 billion, a 9% increase over the first
quarter of 2023. On a GAAP basis, first quarter earnings per
diluted share were $1.34. Adjusted
earnings in the quarter were $1.64
per diluted share, up 10% from the first quarter of 2023. Adjusted
earnings adds back non-cash, after-tax, acquisition-related
intangible amortization of $0.21 per
diluted share and excludes a pre-tax $29.2
million, or $0.10 per diluted
share, charge for integration costs related to the Paragon Medical
acquisition.
GAAP operating income was $417.2
million, or 24.0% of sales. Excluding the Paragon Medical
charge, adjusted operating income was a record $446.4 million, up 10% versus last year's first
quarter, with adjusted operating margins of 25.7%, up 30 basis
points from the first quarter of 2023. A reconciliation of reported
GAAP results to adjusted results is included in the financial
tables accompanying this release and on the AMETEK website.
"I am very pleased with our results in the first quarter," said
David A. Zapico, AMETEK Chairman and
Chief Executive Officer. "Our businesses delivered outstanding
operating performance resulting in record adjusted operating
income, a robust 180 basis points of core margin expansion, and
double-digit growth in adjusted earnings per share. We also
generated strong cash flow in the quarter with operating cash flow
of $410 million and free cash flow
conversion of 123%."
Electronic Instruments Group (EIG)
EIG sales in the
first quarter were $1.16 billion, up
4% from the same quarter in 2023. EIG's operating income in the
quarter increased 14% to $352.9
million with operating income margins a record 30.5%, an
increase of 280 basis points compared to the first quarter of
2023.
"EIG delivered strong results in the first quarter," noted Mr.
Zapico. "Solid sales growth and tremendous operating performance
drove sizeable margin expansion in the quarter. These results
underscore the strength of our EIG business and the effectiveness
of our flexible operating structure."
Electromechanical Group (EMG)
EMG sales in the first
quarter were a record $579.4 million,
up 21% from the first quarter of 2023. On a GAAP basis, EMG's first
quarter operating income was $90.7
million, or 15.7% of sales. Excluding the Paragon
integration costs and the dilutive impact from recent acquisitions,
core operating margins were 24.1% in the quarter.
"Despite the continued headwinds from normalization of inventory
levels across a portion of our customer base, our EMG businesses
delivered solid results in the first quarter. Our teams are doing
an outstanding job managing the short-term impacts on sales and our
businesses are well positioned for solid growth in the second half
of 2024," commented Mr. Zapico.
2024 Outlook
"Our businesses delivered excellent
results in the quarter, highlighting the effectiveness of our
growth model in driving double digit earnings growth. Supported by
our leading positions within attractive market segments, our proven
operating model, and our strong cash flows, we are strategically
positioned for sustained success," noted Mr. Zapico.
"For 2024, we continue to expect overall sales to be up low
double digits on a percentage basis compared to 2023. Adjusted
earnings per diluted share are now expected to be in the range of
$6.74 to $6.86, up 6% to 8% over the comparable basis for
2023. This is an increase from our previous guidance range of
$6.70 to $6.85," he added.
"For the second quarter of 2024, overall sales are expected to
be up mid to high single digits on a percentage basis compared to
the same period last year. Adjusted earnings in the quarter are
anticipated to be in the range of $1.63 to $1.65 per
share, up 4% to 5% compared to the second quarter of 2023,"
concluded Mr. Zapico.
Conference Call
AMETEK will webcast its first quarter
2024 investor conference call on Thursday, May 2, 2024,
beginning at 8:30 AM ET. The live
audio webcast will be available and later archived in the Investors
section of www.ametek.com.
About AMETEK
AMETEK (NYSE: AME) is a leading global
provider of industrial technology solutions serving a diverse set
of attractive niche markets with annualized sales of approximately
$7.0 billion. The AMETEK Growth Model
integrates the Four Growth Strategies - Operational Excellence, New
Product Development, Global and Market Expansion, and Strategic
Acquisitions - with a disciplined focus on cash generation and
capital deployment. AMETEK's objective is double-digit percentage
growth in earnings per share over the business cycle and a superior
return on total capital. Founded in 1930, AMETEK has been listed on
the NYSE for over 90 years and is a component of the S&P 500.
For more information, visit www.ametek.com.
Forward-looking Information
Statements in this news
release relating to future events, such as AMETEK's expected
business and financial performance are "forward-looking
statements." Forward-looking statements are subject to various
factors and uncertainties that may cause actual results to differ
significantly from expectations. These factors and uncertainties
include risks related to AMETEK's ability to consummate and
successfully integrate future acquisitions; risks with
international sales and operations, including supply chain
disruptions; AMETEK's ability to successfully develop new products,
open new facilities or transfer product lines; the price and
availability of raw materials; compliance with government
regulations, including environmental regulations; changes in the
competitive environment or the effects of competition in our
markets; the ability to maintain adequate liquidity and financing
sources; and general economic conditions affecting the industries
we serve. A detailed discussion of these and other factors that may
affect our future results is contained in AMETEK's filings with the
U.S. Securities and Exchange Commission, including its most recent
reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention
or obligation to update or revise any forward-looking
statements.
Contact:
Kevin
Coleman
Vice President, Investor Relations and Treasurer
kevin.coleman@ametek.com
Phone: 610.889.5247
AMETEK,
Inc. Consolidated Statement of Income (In
thousands, except per share
amounts) (Unaudited)
|
|
|
Three Months
Ended
March 31,
|
|
2024
|
|
2023
|
Net
sales
|
$
1,736,180
|
|
$ 1,597,117
|
|
|
|
|
Cost of
sales
|
1,144,681
|
|
1,022,525
|
Selling, general and
administrative
|
174,283
|
|
169,051
|
Total operating
expenses
|
1,318,964
|
|
1,191,576
|
Operating
income
|
417,216
|
|
405,541
|
Interest
expense
|
(35,254)
|
|
(20,569)
|
Other (expense) income,
net
|
(633)
|
|
(5,373)
|
Income before income
taxes
|
381,329
|
|
379,599
|
Provision for income
taxes
|
70,386
|
|
73,887
|
Net
income
|
$
310,943
|
|
$
305,712
|
|
|
|
|
Diluted earnings per
share
|
$
1.34
|
|
$
1.32
|
Basic earnings per
share
|
$
1.35
|
|
$
1.33
|
|
|
|
|
Weighted average common
shares outstanding:
|
|
|
|
Diluted shares
|
232,035
|
|
231,229
|
Basic shares
|
231,097
|
|
230,126
|
|
|
|
|
Dividends per
share
|
$
0.28
|
|
$
0.25
|
AMETEK,
Inc. Information by Business Segment (In
thousands) (Unaudited)
|
|
|
Three Months
Ended March
31,
|
|
2024
|
|
2023
|
Net
sales:
|
|
|
|
Electronic
Instruments
|
$
1,156,779
|
|
$ 1,117,247
|
Electromechanical
|
579,401
|
|
479,870
|
Consolidated net
sales
|
$
1,736,180
|
|
$ 1,597,117
|
|
|
|
|
Operating
income:
|
|
|
|
Segment operating
income:
|
|
|
|
Electronic
Instruments
|
$
352,940
|
|
$
309,747
|
Electromechanical
|
90,691
|
|
120,504
|
Total segment
operating income
|
443,631
|
|
430,251
|
Corporate
administrative expenses
|
(26,415)
|
|
(24,710)
|
Consolidated operating
income
|
$
417,216
|
|
$
405,541
|
AMETEK,
Inc. Condensed Consolidated Balance Sheet (In
thousands)
|
|
|
March
31,
|
|
December
31,
|
|
2024
|
|
2023
|
|
(Unaudited)
|
|
|
ASSETS
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
373,765
|
|
$
409,804
|
Receivables, net
|
983,893
|
|
1,012,932
|
Inventories, net
|
1,127,328
|
|
1,132,471
|
Other current
assets
|
290,516
|
|
269,461
|
Total current assets
|
2,775,502
|
|
2,824,668
|
|
|
|
|
Property, plant and
equipment, net
|
877,420
|
|
891,293
|
Right of use asset,
net
|
219,887
|
|
229,723
|
Goodwill
|
6,438,675
|
|
6,447,629
|
Other intangibles,
investments and other assets
|
4,553,497
|
|
4,630,220
|
Total assets
|
$
14,864,981
|
|
$
15,023,533
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Short-term borrowings and
current portion of long-term debt, net
|
$
1,055,406
|
|
$ 1,417,915
|
Accounts payable and
accruals
|
1,447,102
|
|
1,464,658
|
Total current liabilities
|
2,502,508
|
|
2,882,573
|
|
|
|
|
Long-term debt,
net
|
1,877,772
|
|
1,895,432
|
Deferred income taxes
and other long-term liabilities
|
1,516,486
|
|
1,515,337
|
Stockholders'
equity
|
8,968,215
|
|
8,730,191
|
Total liabilities and stockholders' equity
|
$
14,864,981
|
|
$
15,023,533
|
AMETEK,
Inc. Reconciliations of GAAP to Non-GAAP Financial
Measures (In thousands, except per share
amounts) (Unaudited)
|
|
|
Three Months
Ended March
31,
|
|
2024
|
|
2023
|
EMG Segment operating
income (GAAP)
|
$
90,691
|
|
$
120,504
|
Paragon integration
costs
|
29,231
|
|
—
|
Adjusted EMG Segment
operating income (Non-GAAP)
|
$
119,922
|
|
$
120,504
|
|
|
|
|
Operating income
(GAAP)
|
$
417,216
|
|
$
405,541
|
Paragon integration
costs
|
29,231
|
|
—
|
Adjusted Operating
income (Non-GAAP)
|
$
446,447
|
|
$
405,541
|
|
|
|
|
Diluted earnings per
share (GAAP)
|
$
1.34
|
|
$
1.32
|
Paragon integration
costs
|
0.13
|
|
—
|
Income tax benefit on
Paragon integration costs
|
(0.03)
|
|
—
|
Pretax amortization of
acquisition-related intangible assets
|
0.27
|
|
0.22
|
Income tax benefit on
amortization of acquisition-related intangible assets
|
(0.06)
|
|
(0.05)
|
Rounding
|
(0.01)
|
|
—
|
Adjusted Diluted
earnings per share (Non-GAAP)
|
$
1.64
|
|
$
1.49
|
|
|
|
|
Cash provided by
operating activities (GAAP)
|
$
410,227
|
|
$
386,536
|
Deduct: Capital
expenditures
|
(27,652)
|
|
(20,006)
|
Free cash flow
(Non-GAAP)
|
$
382,575
|
|
$
366,530
|
Free cash flow
conversion (Non-GAAP)
|
123 %
|
|
120 %
|
|
|
|
|
EMG Segment operating
margin (GAAP)
|
15.7 %
|
|
25.1 %
|
Paragon integration
costs
|
5.0 %
|
|
— %
|
Adjusted EMG Segment
operating margin (Non-GAAP)
|
20.7 %
|
|
25.1 %
|
Dilutive impact of
acquisitions
|
3.4 %
|
|
— %
|
Adjusted EMG Core
Segment operating margin (Non-GAAP)
|
24.1 %
|
|
25.1 %
|
|
|
|
|
Operating income margin
(GAAP)
|
24.0 %
|
|
25.4 %
|
Paragon integration
costs
|
1.7 %
|
|
— %
|
Adjusted Operating
income margin (Non-GAAP)
|
25.7 %
|
|
25.4 %
|
Dilutive impact of
acquisitions
|
1.5 %
|
|
— %
|
Adjusted Core Operating
income margin (Non-GAAP)
|
27.2 %
|
|
25.4 %
|
AMETEK,
Inc. Reconciliations of GAAP to Non-GAAP Financial
Measures (Unaudited)
|
|
|
Forecasted Diluted
Earnings Per Share
|
|
Three Months
Ended
|
|
Year
Ended
|
|
June 30,
2024
|
|
December 31,
2024
|
|
Low
|
|
High
|
|
Low
|
|
High
|
|
|
|
|
|
|
|
|
Diluted earnings per
share (GAAP)
|
$
1.42
|
|
$
1.44
|
|
$
5.82
|
|
$
5.94
|
Paragon integration
costs
|
—
|
|
—
|
|
0.13
|
|
0.13
|
Income tax benefit on
Paragon integration costs
|
—
|
|
—
|
|
(0.03)
|
|
(0.03)
|
Pretax amortization of
acquisition-related intangible
assets
|
0.27
|
|
0.27
|
|
1.08
|
|
1.08
|
Income tax benefit on
amortization of acquisition-
related intangible assets
|
(0.06)
|
|
(0.06)
|
|
(0.26)
|
|
(0.26)
|
Adjusted Diluted
earnings per share (Non-GAAP)
|
$
1.63
|
|
$
1.65
|
|
$
6.74
|
|
$
6.86
|
Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements
presented on a U.S. generally accepted accounting principles
("GAAP") basis with certain non-GAAP financial information to
provide investors with greater insight, increased transparency and
allow for a more comprehensive understanding of the information
used by management in its financial and operational
decision-making. Reconciliation of non-GAAP measures to their
most directly comparable GAAP measures are included in the
accompanying financial tables. These non-GAAP financial measures
should be considered in addition to, and not as a replacement for,
or superior to, the comparable GAAP measure, and may not be
comparable to similarly titled measures reported by other
companies.
The Company believes that these measures provide useful
information to investors by reflecting additional ways of viewing
AMETEK's operations that, when reconciled to the comparable GAAP
measure, helps our investors to better understand the long-term
profitability trends of our business, and facilitates easier
comparisons of our profitability to prior and future periods and to
our peers.
View original
content:https://www.prnewswire.com/news-releases/ametek-announces-record-first-quarter-results-and-raises-2024-guidance-302133734.html
SOURCE AMETEK, Inc.